Edgewell Q3: Organic Sales Return to Growth, but Margins Squeezed by Inflation and Restructuring
EPC sits 87% above its 52-week low of $15.725.
Summary
Edgewell returned to organic sales growth in Q3, but margins compressed sharply due to inflation and restructuring costs. The balance sheet is flush with cash after the Feminine Care sale, providing runway for the ongoing operational overhaul.
Key Events · Earnings and Guidance · EPC
-
Organic Sales Return to Growth
Q3 organic net sales rose 1.1% to $570.1M, driven by 3.0% growth in North America across Sun, Skin Care, and Grooming. International sales declined 1.4% due to Middle East disruptions and supply chain impacts from manufacturing consolidation.
-
Gross Margin Compressed 210 bps
Gross margin fell to 42.5% from 44.6% a year ago. Productivity savings of ~200 bps and favorable currency were more than offset by 160 bps of core inflation and net tariffs, plus 110 bps of unfavorable mix and promotions.
-
Restructuring Charges Weigh on Earnings
Restructuring and related costs totaled $24.5M in Q3, including $17.8M for the Mexico facility consolidation and $2.1M for Wet Shave consolidation. Operating income dropped 44% to $25.0M.
-
Balance Sheet Strengthened by Divestiture
Cash and cash equivalents rose to $397.1M from $225.7M at fiscal year-end, primarily from the $338.9M Feminine Care sale proceeds. The $425M revolving credit facility was fully repaid, leaving $418.8M available.
Analysis · EPC · Industrial Applications And Services
Edgewell Personal Care reported Q3 FY2026 results with organic sales growth of 1.1%, breaking a recent streak of declines. However, gross margin contracted 210 basis points to 42.5% as inflation, tariffs, and unfavorable mix more than offset productivity savings. Operating income fell 44% to $25.0M, weighed down by $24.5M in restructuring charges tied to the ongoing consolidation of Mexico facilities and Wet Shave operations. The balance sheet strengthened after the Feminine Care divestiture — cash jumped to $397.1M and the revolver was fully repaid — giving the company ample liquidity to fund its turnaround. Adjusted EPS of $0.72 was flat year-over-year, but the underlying profitability erosion and heavy restructuring spend signal that the operational overhaul is still a drag on earnings. The stock trades near its 52-week high, reflecting optimism around the rejected $30/share takeover bid in June, but this quarter's margin pressure and elevated one-time costs may test that enthusiasm.
At the time of this filing, EPC was trading at $29.35 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $1.4B. The 52-week trading range was $15.73 to $29.95. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.